NGL Fine Chem Submits FY26 BRSR Report
NGL Fine-Chem Limited has submitted its Business Responsibility and Sustainability Reporting (BRSR) for the financial year 2025-26, in compliance with SEBI (LODR) Regulations, 2015. The report, which forms part of the Integrated Annual Report, details the company's commitment to integrating Environmental, Social, and Governance (ESG) principles into its core strategy. NGL Fine-Chem emphasizes sustainable operations for enduring enterprise value, focusing on environmental stewardship, social capital, and robust governance. The company manufactures pharmaceuticals and intermediates for veterinary and human health, with 100% of its turnover derived from this activity. Operations are primarily domestic, with a significant international market presence across 54 countries.
Key Highlights
- NGL Fine-Chem filed its FY26 Business Responsibility and Sustainability Report.
- The report integrates ESG principles into the company's core strategy.
- Company focuses on environmental, social, and governance pillars.
- Pharmaceutical manufacturing accounts for 100% of turnover.
- Operations serve domestic and international markets.
Price Impact
More from NGLFINE